SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001725160-21-000065
Filing Date
2021-03-19
Accepted
2021-03-19 16:28:00
Documents
6
Effectiveness Date
2021-03-19

Document Format Files

Seq Description Document Type Size
1 S-8 zentalis-formsx8march2021.htm S-8 101097
2 EX-5.1 exhibit51opiniontoforms-.htm EX-5.1 5002
3 EX-23.1 a231-consentofey.htm EX-23.1 2484
4 EX-99.1 exhibit991-espp.htm EX-99.1 127094
5 GRAPHIC exhibit51opiniontoforms-001.jpg GRAPHIC 218937
6 GRAPHIC exhibit51opiniontoforms-002.jpg GRAPHIC 72437
  Complete submission text file 0001725160-21-000065.txt   638446
Mailing Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Filer) CIK: 0001725160 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-254506 | Film No.: 21758510
SIC: 2834 Pharmaceutical Preparations